Luxembourg Times Facebook ad: “Weight loss injections: More than just a lifestyle drug”

Ran for 110 days, from January 21 to May 11, 2026, the last day Crush saw it.
Run by Luxembourg Times on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 4361989917411436
- Platforms
- Facebook, Instagram, Audience Network, Messenger and Threads
- Relaunches
- 0
- EU reach
- 89,298
- Niche
- Finance & Trading
Ad text
💉 Weight loss injections with semaglutide or tirzepatide are making headlines – but how do they actually work? Professor Frank Tacke from Charité Berlin explains 👇
Where the ad sends people
luxtimes.lu
Weight loss injections: More than just a lifestyle drug
Professor Frank Tacke, clinic director at Charité Berlin, explains the opportunities and risks of the medication
Learn more: luxtimes.lu(opens in a new tab)









